Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04725422 · ClinicalTrials.gov registry record
CHronic Nonbacterial Osteomyelitis International Registry
A clinical trial of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT04725422: Recruiting study of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis, sponsored by Seattle Children's Hospital.
NCT04725422 is a study of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04725422, a study of Chronic Nonbacterial Osteomyelitis and Chronic Recurrent Multifocal Osteomyelitis, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 years.
Primary Outcome
Disease activity score is calculated as the sum of number of clinical lesion count, patient global assessment (0-10), physician global assessment (0-10)
Conditions Studied
Interventions
- DRUG Zoledronic acid
- DRUG Methotrexate
- DRUG Leflunomide
- DRUG Sulfasalazine
- DRUG Pamidronate
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2050-08 |
What NCT04725422 shows while recruiting
NCT04725422 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Chronic Nonbacterial Osteomyelitis appearing as the primary indexed condition, and to 5 interventions - of which Zoledronic acid is the first listed.
NCT04725422 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04725422 about?
NCT04725422 is a clinical study titled "CHronic Nonbacterial Osteomyelitis International Registry". The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 ...
What is the current status of trial NCT04725422?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2018-08-01. Estimated completion is 2050-08.
What conditions does trial NCT04725422 study?
This clinical trial studies the following conditions: Chronic Nonbacterial Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis.
What interventions are being tested in trial NCT04725422?
The interventions under investigation include: Zoledronic acid (DRUG), Methotrexate (DRUG), Leflunomide (DRUG), Sulfasalazine (DRUG), Pamidronate (DRUG).
Who is sponsoring clinical trial NCT04725422?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04725422 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI